Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
These products are not drugs, foods, cosmetics, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use
Tesofensine offers a central nervous system approach, suppressing appetite while simultaneously increasing resting energy expenditure through triple monoamine reuptake inhibition
As of 2026, retatrutide has not received marketing authorisation from the MHRA or EMA and is only accessible within authorised clinical trials
&srotate=0)
A standard 3.2 mg KLOW dose contains only 400 mcg of full-length TB-4
US$ 23.93
US$ 22.40
US$ 26.49
.webp)
US$ 23.94
